×




Plavix: Drugs in the Age of Personalized Medicine Negotiation Strategy / MBA Resources

Introduction to Negotiation Strategy

Negotiation Strategy solution for Plavix: Drugs in the Age of Personalized Medicine case study


At Oak Spring University, we provide corporate level professional Negotiation Strategy and other business case study solution. Plavix: Drugs in the Age of Personalized Medicine case study is a Harvard Business School (HBR) case study written by Richard G. Hamermesh, Mara G. Aspinall, Rachel Gordon. The Plavix: Drugs in the Age of Personalized Medicine (referred as “Plavix Plavix's” from here on) case study provides evaluation & decision scenario in field of Innovation & Entrepreneurship. It also touches upon business topics such as - negotiation strategy , negotiation framework, Marketing.

Negotiation strategy solution for case study Plavix: Drugs in the Age of Personalized Medicine ” provides a comprehensive framework to analyse all issues at hand and reach a unambiguous negotiated agreement. At Oak Spring University, we provide comprehensive negotiation strategies that have proven their worth both in the academic sphere and corporate world.


BATNA in Negotiation Strategy


Three questions every negotiator should ask before entering into a negotiation process-

What’s my BATNA (Best Alternative To a Negotiated Agreement) – my walkaway option if the deal fails?

What are my most important interests, in ranked order?

What is the other side’s BATNA, and what are his interests?



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now




Case Description of Plavix: Drugs in the Age of Personalized Medicine Case Study


PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon and recently new data had been discovered which indicated that a small subset of the population would be at risk for stroke, heart attack or even death if they took PIavix. As a result the FDA had added a black box warning-the agency's most severe--to Plavix's label in 2010. In addition, it had been discovered that the common combination of Plavix and Prilosec, an over-the-counter drug, could adversely affect patients. Finally, Plavix faced new competition from two new drugs with different mechanisms of action. This case reviews the recent history of Plavix in greater detail to encourage a discussion of the following questions: How might the current manufacturers of Plavix handle these emerging threats to their leading blockbuster? How might Plavix's potential competitors utilize Plavix's mixed history to their advantage? How should genotyping be integrated into the clinical care of patients in the light of emerging knowledge?


Case Authors : Richard G. Hamermesh, Mara G. Aspinall, Rachel Gordon

Topic : Innovation & Entrepreneurship

Related Areas : Marketing




Seven Elemental Tools of Negotiation that can be used in Plavix: Drugs in the Age of Personalized Medicine solution


1. Satisfies everyone’s core interests (yours and theirs)


By interests, we do not mean the preconceived demands or positions that you or the other party may have, but rather the underlying needs, aims, fears, and concerns that shape what you want. Negotiation is more than getting what you want. It is not winning at all cost. Number of times Win-Win is better option that outright winning or getting what you want.





2. Is the best of many options

Options are the solutions you generate that could meet your and your counterpart’s interests . Often people come to negotiations with very fixed ideas and things they want to achieve. This strategy leaves unexplored options which might be even better than the one that one party wanted to achieve. So always try to provide as many options as possible during the negotiation process . The best outcome should be out of many options rather than few options.


3. Meets legitimate, fair standards

When soft bargainers meet hard bargainers there is always the danger of soft bargainers ceding more than what is necessary. To avoid this scenario you should always focus on legitimate standards or expectations, clearly understanding the arbitrage . Standards are often external and objective measures to assess the fairness such as rules and regulations, financial values & resources , market prices etc. If the negotiated agreement is going beyond the industry norms or established standards of fairness then it is prudent to get out of the negotiation.


4. Is better than your alternatives or BATNA

Every negotiators going into the negotiations should always work out the “what if” scenario. The negotiating parties in the “Plavix: Drugs in the Age of Personalized Medicine” has three to four plausible scenarios. The negotiating protagonist needs to have clear idea of – what will happen if the negotiations fail. To put it in the negotiating literature – BATNA - Best Alternative to a Negotiated Agreement. If the negotiated agreement is not better than BATNA (Negotiations options), then there is no point in accepting the negotiated solution.


5. Is comprised of clear, realistic commitments

One of the biggest problems in implementing the negotiated agreements in corporate world is – the ambiguity in the negotiated agreement. Sometimes the negotiated agreements are not realistic or various parties interpret the outcomes based on their understanding of the situation. It is critical to do negotiations as water tight as possible so that there is less scope for ambiguity.


6. Is the result of effective communication?

Many negotiators make the mistake of focusing only on the substance of the negotiation (interests, options, standards, and so on). How you communicate about that substance, however, can make all the difference. The language you use and the way that you build understanding, jointly solve problems, and together determine the process of the negotiation with your counterpart make your negotiation more efficient, yield clear agreements that each party understands, and help you build better relationships.


7. Managing relationship with counterparty

Another critical factor in the success of your negotiation is how you manage your relationship with your counterpart and other people doing the mediation. According to “Richard G. Hamermesh, Mara G. Aspinall, Rachel Gordon”, the protagonist may want to establish a new connection or repair a damaged one; in any case, you want to build a strong working relationship built on mutual respect, well-established trust, and a side-by-side problem- solving approach.




Different types of negotiators – what is your style of negotiation

According to Harvard Business Review , there are three types of negotiators – Hard Bargainers, Soft Bargainers, and Principled Bargainers.

Hard Bargainers – These people see negotiations as an activity that they need to win. They are less focused less on the real objectives of the negotiations but more on winning. In the “Plavix: Drugs in the Age of Personalized Medicine ”, do you think a hard bargaining strategy will deliver desired results? Hard bargainers are easy to negotiate with as they often have a very predictable strategy

Soft Bargainers – These people are focused on relationship rather than hard outcomes of the negotiations. It doesn’t mean they are pushovers. These negotiators often scribe to long term relationship rather than immediate bargain.

Principled Bargainers – As explained in the seven elemental tools of negotiations above, these negotiators are more concern about the standards and norms of fairness. They often have inclusive approach to negotiations and like to work on numerous solutions that can improve the BATNA of both parties.

Open lines of communication between parties in the case study “Plavix: Drugs in the Age of Personalized Medicine” can make for an effective negotiation strategy and will make it easier to negotiate with this party the next time as well.





NPV Analysis of Plavix: Drugs in the Age of Personalized Medicine



References & Further Readings

Richard G. Hamermesh, Mara G. Aspinall, Rachel Gordon (2018), "Plavix: Drugs in the Age of Personalized Medicine Harvard Business Review Case Study. Published by HBR Publications.


NTT Docomo, Inc. SWOT Analysis / TOWS Matrix

Services , Communications Services


Dalian Energas Gas-System SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Hangzhou Zhongya Machinery SWOT Analysis / TOWS Matrix

Basic Materials , Containers & Packaging


Cisco SWOT Analysis / TOWS Matrix

Technology , Communications Equipment


Baotou Huazi Industry SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Harte Gold Corp. SWOT Analysis / TOWS Matrix

Basic Materials , Gold & Silver


Imperial Brands SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Tobacco


I X Knowledge SWOT Analysis / TOWS Matrix

Technology , Software & Programming


Fresenius SE SWOT Analysis / TOWS Matrix

Healthcare , Healthcare Facilities


Neo Technical System SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods